$0.50 0.00 (+0.04%)
11/6/2009 3:59 PM

Generex Biotechnology Corp (GNBT)

CAPS Rating: 3 out of 5

The Company is engaged primarily in the research, development and commercialization of drug delivery systems and technologies.

Current Price $0.50 Mkt Cap $123.47M
Open $0.50 P/E Ratio 0.00
Prev. Close $0.50 Div. (Yield) N/A (N/A)
Daily Range $0.49 - $0.51 Volume 1,852,515
52-Wk Range $0.08 - $1.14 Avg. Daily Vol. 3,844,000

GNBT News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

185 Outperform
11 Underperform
 

All-Star Members

23 Outperform
3 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top GNBT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Voyt608 (82.93)
Submitted January 08, 2008

GNBT's Oral insulin delivery system is a significant advancement in the treatment of Diabetes Mellitus and will be soon approved for use in the USA. It will be a cash cow, funding the companies cancer treatment programs for the foreseeable future.More

2 Comments | Reply | Report this Post

pobeda1 (21.20)
Submitted October 23, 2006

Incompetent management. Achieved virtually nothing in the past 10 years. Extremely poor fundamentals. Conduct unconventional clinical trials to avoid FDA pathway.

0 Comments | Reply | Report this Post
GNBT VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about GNBT.

Recs

2
Member Avatar Voyt608 (82.93) Submitted: 1/7/2008 9:51:57 PM : Outperform Start Price: $1.59 GNBT Score: -47.13

GNBT's Oral insulin delivery system is a significant advancement in the treatment of Diabetes Mellitus and will be soon approved for use in the USA. It will be a cash cow, funding the companies cancer treatment programs for the foreseeable future.

I expect GNBT to be a blockbuster stock.

Report this Post 2 Comments | Reply | Permalink

Recs

0
Member Avatar Biotech2008 (89.46) Submitted: 1/4/2008 10:08:13 PM : Outperform Start Price: $1.64 GNBT Score: -48.24

jpg101 @5.53

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar edjab (< 20) Submitted: 1/2/2008 9:37:52 AM : Outperform Start Price: $1.65 GNBT Score: -45.77

Good potential. desired remedy. easy medication control for diabetes & others.

Report this Post 0 Comments | Reply | Permalink
View All 50 Pitches »

Leaderboard

Find the members with the highest scoring picks in GNBT.

Score Leader

RustySmarr

RustySmarr (74.85) Score: +61.88

The Score Leader is the member with the highest score across all their picks in GNBT.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
RustySmarr 74.85 10/13/2006 Underperform NS $2.31 -78.35% -16.47% +61.88
khsabet 67.77 10/17/2006 Underperform NS $2.08 -75.96% -16.60% +59.36
pobeda1 21.20 10/23/2006 Underperform 5Y $2.09 -76.08% -16.74% +59.34 1 Comment
edawis 50.70 12/11/2006 Underperform 3M $1.82 -72.53% -19.60% +52.93
Tikigod02 47.16 12/19/2007 3/6/2009 Underperform 3W $1.80 -72.22% -22.82% +49.40
honcharella 88.83 3/23/2007 Underperform 3Y $1.67 -70.06% -21.06% +49.00
TheWINingest 31.81 6/12/2007 Underperform 5Y $1.86 -73.12% -25.13% +47.99
dow13000 91.94 6/12/2007 Underperform 5Y $1.71 -70.76% -24.81% +45.95
justquit < 20 11/30/2007 Underperform 3M $1.70 -70.59% -24.69% +45.90
andrews640 63.09 4/23/2007 Underperform 1Y $1.63 -69.33% -23.67% +45.66 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackRodmanRen < 20 6/13/2007 Outperform NS $1.89 -73.54% -24.74% -48.80

Featured Broker Partners